<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate whether <z:chebi fb="0" ids="23528">cytochalasin</z:chebi> D can induce antitumor activities in a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> model </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Murine CT26 colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cells were cultured in vitro and <z:chebi fb="0" ids="23528">cytochalasin</z:chebi> D was used as a cytotoxic agent to detect its capabilities of inhibiting CT26 cell proliferation and inducing cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by <z:chebi fb="0" ids="53233">MTT</z:chebi> and a TUNEL-based <z:mpath ids='MPATH_3'>apoptosis</z:mpath> assay </plain></SENT>
<SENT sid="2" pm="."><plain>Murine CT26 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> model was established to observe the <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and survival time </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> tissues were used to detect the microvessel density by immunohistochemistry </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, alginate encapsulated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell assay was used to quantify the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> in vivo </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: <z:chebi fb="0" ids="23528">Cytochalasin</z:chebi> D inhibited CT26 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell proliferation in time and dose dependent manner and induced significant CT26 cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, which almost reached the level induced by the positive control nuclease </plain></SENT>
<SENT sid="6" pm="."><plain>The optimum effective dose of <z:chebi fb="0" ids="23528">cytochalasin</z:chebi> D for in vivo therapy was about 50 mg/kg </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="23528">Cytochalasin</z:chebi> D in vivo treatment significantly inhibited <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and prolonged the survival times in CT26 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-bearing mice </plain></SENT>
<SENT sid="8" pm="."><plain>The results of immunohistochemistry analysis and alginate encapsulation assay indicated that the <z:chebi fb="0" ids="23528">cytochalasin</z:chebi> D could effectively inhibited <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="23528">Cytochalasin</z:chebi> D inhibits CT26 <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> potentially through inhibition of cell proliferation, induction of cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and suppression of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
</text></document>